Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Kiß, O.; Scott, P.; Behe, M.; Penuelas, I.; Passchier, J.; Rey, A.; Patt, M.; Aime, S.; Jalilian, A.; Laverman, P.; Cheng, Z.; Faivre Chauvet, A.; Engle, J.; Cleeren, F.; Zhu, H.; Vercouille, J.; van Dam, M.; Zhang, M.-R.; Perk, L.; Guillet, B.; Alves, F.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Main Body: This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field, and include new PET-labelling methods for 11C and 18F, the importance of choosing the proper chelator for a given radioactive metal ion, implications of total body PET on use of radiopharmaceuticals, legislation issues and radionuclide therapy including the emerging role of 161Tb.

Permalink: https://www.hzdr.de/publications/Publ-36590